Search

Your search keyword '"S, Makki"' showing total 141 results

Search Constraints

Start Over You searched for: Author "S, Makki" Remove constraint Author: "S, Makki"
141 results on '"S, Makki"'

Search Results

101. Pain and quality of life of patients with end-stage renal disease undergoing hemodialysis in Aseer region, Saudi Arabia.

102. Community Pharmacists' Knowledge and Perception towards Telepharmacy Services and Willingness to Practice It in Light of COVID-19.

103. The influence of the COVID-19 pandemic on the psychological well-being of college students: a cross-sectional study.

104. Detection and analysis of potential drug-drug interactions among patients admitted to the cardiac care unit in a tertiary care hospital.

105. Beliefs and Barriers to COVID-19 Vaccine Acceptance in Three Countries with Different Human Development Index (HDI) Scores: A Comparative Study.

106. Child labor in Tehran, Iran: Abuses experienced in work environments.

107. Takayasu's arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?

108. The Knowledge and Attitude of the Community from the Aseer Region, Saudi Arabia, Toward COVID-19 and Their Precautionary Measures Against the Disease.

109. Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population.

110. Clinical characteristics and public health management of invasive meningococcal group W disease in the East Midlands region of England, United Kingdom, 2011 to 2013.

111. Effects of refractive index mismatch in optical CT imaging of polymer gel dosimeters.

112. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.

113. An audit of neonatal and infant hepatitis B immunisation and serological testing in two counties of England, 2007-12.

114. Assessment of principal parabens used in cosmetics after their passage through human epidermis-dermis layers (ex-vivo study).

115. Evaluation of a sunscreen photoprotective effect by ascorbic acid assessment in human dermis using microdialysis and gas chromatography mass spectrometry.

116. In vivo assessment of iron and ascorbic acid in psoriatic dermis.

117. Serogroup W-135 meningococcal disease during the Hajj, 2000.

118. Iron and ascorbic acid concentrations in human dermis with regard to age and body sites.

119. High iron and low ascorbic acid concentrations in the dermis of atopic dermatitis patients.

120. Validation of a microdialysis-gas chromatographic-mass spectrometric method to assess 8-methoxypsoralen in psoriatic patient dermis.

121. Decrease in skin ascorbic acid concentration with age.

122. Iron concentrations in human dermis assessed by microdialysis associated with atomic absorption spectrometry.

124. High-performance thin-layer chromatographic determination of 5-methoxypsoralen in serum from patients.

125. Spectrofluorimetric determination of 5-methoxypsoralen pharmacokinetic in patients' serum.

126. Lipophilicity determination of psoralens used in therapy through solubility and partitioning: comparison of theoretical and experimental approaches.

127. HLA DR, DQA, DQB and DP antigens in patients allergic to nickel.

128. Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation.

129. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.

130. Serum free 5-methoxypsoralen fraction in health and psoriasis: relationship with human serum albumin concentration.

131. A new micronized 5-methoxypsoralen preparation. Higher bioavailability and lower UVA dose requirement.

132. Simple equilibrium dialysis-high-performance liquid chromatographic method for the in vitro assessment of 5-methoxypsoralen bound to human albumin.

133. Peak blistering point: influence on fluid levels of 5-MOP in human skin in vivo after systemic administration.

134. Use of a surface recovery technique to evaluate percutaneous absorption of 5-methoxypsoralen in humans.

135. Chronopharmacokinetics of 5-methoxypsoralen.

136. A quantitative method for the assessment of the microtopography of human skin.

137. Skin care in childhood.

141. [The effects of glucose on Mycoplasma].

Catalog

Books, media, physical & digital resources